NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/11/2025
Back to search
Official data from USPTO
OTTER BIOTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
03/11/2025
Trademark type
Combined
Nice classes
1, 42
Filing date
02/12/2023
Registration date
03/11/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/11/2025
Last transaction
03/11/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/24/2023
First use in commerce
03/12/2024
Drawing code
3
Owner type
16
Owner location
Newark, DE
Examiner
BROWNING, KATHRYN
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a design element featuring a "Y"shape connected to two curved ribbons. The "Y" shape is in blue, green, and red, with a white background. The two curved ribbons are in blue. To the right of the design is the literal element, "OTTER BIOTECH" in blue.
Holders and representatives
Holders
Otter Biotech LLC
Otter Biotech LLC
Zhu, Yan
Representatives
Otter Biotech LLC
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Protein for industrial use; Laboratory chemicalsan antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use
Class 42
Research and development services in the field of antibodies
Publications
History of USPTO decisions and trademark events.
38 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/11/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/20/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/20/2025
DOCK
ASSIGNED TO EXAMINER
01/17/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/07/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/07/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/08/2024
GNFR
FINAL REFUSAL E-MAILED
10/08/2024
CNFR
SU - FINAL REFUSAL - WRITTEN
10/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/07/2024
ALIE
ASSIGNED TO LIE
10/07/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/17/2024
DOCK
ASSIGNED TO EXAMINER
05/15/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/19/2024
GNRT
NON-FINAL ACTION E-MAILED
04/19/2024
CNRT
SU - NON-FINAL ACTION - WRITTEN
04/19/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/17/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/17/2024
IUAF
USE AMENDMENT FILED
03/27/2024
EISU
TEAS STATEMENT OF USE RECEIVED
03/27/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/17/2023
PUBO
PUBLISHED FOR OPPOSITION
10/17/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/27/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/12/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/25/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/09/2023
GNRT
NON-FINAL ACTION E-MAILED
05/09/2023
CNRT
NON-FINAL ACTION WRITTEN
05/09/2023
DOCK
ASSIGNED TO EXAMINER
05/08/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/03/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/02/2023
NWAP
NEW APPLICATION ENTERED
02/15/2023
Continuous trademark protection
Get notified about every new filing that threatens OTTER BIOTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.